| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maren Schrölkamp, Poul J Jennum, Steen Gammeltoft, Anja Holm, Birgitte R Kornum, Stine Knudse. Normal Morning Melanin-Concentrating Hormone Levels and No Association with Rapid Eye Movement or Non-Rapid Eye Movement Sleep Parameters in Narcolepsy Type 1 and Type 2. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. vol 13. issue 2. 2017-12-11. PMID:27855741. |
other than hypocretin-1 (hcrt-1) deficiency in narcolepsy type 1 (nt1), the neurochemical imbalance of nt1 and narcolepsy type 2 (nt2) with normal hcrt-1 levels is largely unknown. |
2017-12-11 |
2023-08-13 |
Not clear |
| Virginia Ponziani, Monia Gennari, Fabio Pizza, Antonio Balsamo, Filippo Bernardi, Giuseppe Plazz. Growing Up with Type 1 Narcolepsy: Its Anthropometric and Endocrine Features. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine. vol 12. issue 12. 2017-11-27. PMID:27707443. |
to evaluate the effect of type 1 narcolepsy (nt1) on anthropometric and endocrine features in childhood/adolescence, focusing on patterns and correlates of weight, pubertal development, and growth in treated and untreated patients. |
2017-11-27 |
2023-08-13 |
Not clear |
| Anders Vinther Olsen, Jens Stephansen, Eileen Leary, Paul E Peppard, Hong Sheungshul, Poul Jørgen Jennum, Helge Sorensen, Emmanuel Migno. Diagnostic value of sleep stage dissociation as visualized on a 2-dimensional sleep state space in human narcolepsy. Journal of neuroscience methods. vol 282. 2017-11-16. PMID:28219726. |
type 1 narcolepsy (nt1) is characterized by symptoms believed to represent rapid eye movement (rem) sleep stage dissociations, occurrences where features of wake and rem sleep are intermingled, resulting in a mixed state. |
2017-11-16 |
2023-08-13 |
human |
| Mariusz Sieminski, Kamil Chwojnicki, Tomi Sarkanen, Markku Partine. The relationship between orexin levels and blood pressure changes in patients with narcolepsy. PloS one. vol 12. issue 10. 2017-10-23. PMID:29023559. |
narcolepsy type 1 (nt1) is caused by a deficiency or absence of the neurotransmitter orexin. |
2017-10-23 |
2023-08-13 |
Not clear |
| Francesca Letizia Rocca, Elena Finotti, Fabio Pizza, Francesca Ingravallo, Michela Gatta, Oliviero Bruni, Giuseppe Plazz. Psychosocial Profile and Quality of Life in Children With Type 1 Narcolepsy: A Case-Control Study. Sleep. vol 39. issue 7. 2017-10-13. PMID:27166243. |
to investigate behavioral aspects and quality of life in children and adolescents with type 1 narcolepsy (nt1). |
2017-10-13 |
2023-08-13 |
Not clear |
| C Monaca, P Franco, P Philip, Y Dauvillier. Revue neurologique. vol 173. issue 1-2. 2017-09-26. PMID:27838095. |
in the new international classification of sleep disorders (icsd-3), narcolepsy is differentiated into two distinct pathologies: type 1 narcolepsy (nt1) and type 2 narcolepsy (nt2). |
2017-09-26 |
2023-08-13 |
Not clear |
| R Lopez, I Arnulf, X Drouot, M Lecendreux, Y Dauvillier. French consensus. Management of patients with hypersomnia: Which strategy? Revue neurologique. vol 173. issue 1-2. 2017-09-26. PMID:27865546. |
central hypersomnias principally involves type 1 narcolepsy (nt1), type 2 narcolepsy (nt2) and idiopathic hypersomnia (ih). |
2017-09-26 |
2023-08-13 |
Not clear |
| Michel Lecendreux, Guillaume Churlaud, Fabien Pitoiset, Armelle Regnault, Tu Anh Tran, Roland Liblau, David Klatzmann, Michelle Rosenzwaj. Narcolepsy Type 1 Is Associated with a Systemic Increase and Activation of Regulatory T Cells and with a Systemic Activation of Global T Cells. PloS one. vol 12. issue 1. 2017-08-10. PMID:28107375. |
narcolepsy type 1 (nt1) has been shown to result from a selective loss of hypothalamic hypocretin-secreting neurons with patients typically showing low csf-hypocretin levels (<110 pg/ml). |
2017-08-10 |
2023-08-13 |
human |
| Raffaele Ferri, Fabio Pizza, Stefano Vandi, Martina Iloti, Giuseppe Plazz. Decreased sleep stage transition pattern complexity in narcolepsy type 1. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology. vol 127. issue 8. 2017-05-26. PMID:27417057. |
to analyze the complexity of the nocturnal sleep stage sequence in central disorders of hypersomnolence (cdh), with the hypothesis that narcolepsy type 1 (nt1) might exhibit distinctive sleep stage sequence organization and complexity. |
2017-05-26 |
2023-08-13 |
Not clear |
| Yves Dauvilliers, Severine Beziat, Carole Pesenti, Regis Lopez, Lucie Barateau, Bertrand Carlander, Gianina Luca, Mehdi Tafti, Charles M Morin, Michel Billiard, Isabelle Jaussen. Measurement of narcolepsy symptoms: The Narcolepsy Severity Scale. Neurology. vol 88. issue 14. 2017-05-23. PMID:28258080. |
to validate the narcolepsy severity scale (nss), a brief clinical instrument to evaluate the severity and consequences of symptoms in patients with narcolepsy type 1 (nt1). |
2017-05-23 |
2023-08-13 |
Not clear |
| Lucie Barateau, Régis Lopez, Isabelle Arnulf, Michel Lecendreux, Patricia Franco, Xavier Drouot, Smaranda Leu-Semenescu, Isabelle Jaussent, Yves Dauvillier. Comorbidity between central disorders of hypersomnolence and immune-based disorders. Neurology. vol 88. issue 1. 2017-05-18. PMID:27864522. |
to assess and compare the frequencies of personal and family history of autoimmune diseases (aid), autoinflammatory disorders (id), and allergies in a population of patients, adults and children, with narcolepsy type 1 (nt1), narcolepsy type 2 (nt2), and idiopathic hypersomnia (ih), 3 central hypersomnia disorders, and healthy controls. |
2017-05-18 |
2023-08-13 |
Not clear |
| Milena Vrana, Vera Siffnerova, Pavla Pecherkova, Eva Ratajova, Karel Sonk. Distribution of HLA-DQB1 in Czech Patients with Central Hypersomnias. Archivum immunologiae et therapiae experimentalis. vol 64. issue Suppl 1. 2017-04-13. PMID:28083611. |
the aim of our study was to analyze the distribution of hla-dqb1 in czech patients with central hypersomnias and differences between diagnostic groups of narcolepsy type 1 (nt1), type 2 (nt2), idiopathic hypersomnia (ih) and no central hypersomnia subjects (no-ch). |
2017-04-13 |
2023-08-13 |
human |
| Lucie Barateau, Isabelle Jaussent, Régis Lopez, Benjamin Boutrel, Smaranda Leu-Semenescu, Isabelle Arnulf, Yves Dauvillier. Smoking, Alcohol, Drug Use, Abuse and Dependence in Narcolepsy and Idiopathic Hypersomnia: A Case-Control Study. Sleep. vol 39. issue 3. 2016-12-13. PMID:26564129. |
our aim was to assess the frequencies of smoking, alcohol and drug use, abuse and dependence in narcolepsy type 1 (nt1, hypocretin-deficient), narcolepsy type 2 (nt2), idiopathic hypersomnia (ih) (non-hypocretin-deficient conditions), in comparison to controls. |
2016-12-13 |
2023-08-13 |
Not clear |
| Smaranda Leu-Semenescu, Pauline Louis, Isabelle Arnul. Benefits and risk of sodium oxybate in idiopathic hypersomnia versus narcolepsy type 1: a chart review. Sleep medicine. vol 17. 2016-12-13. PMID:26847972. |
sodium oxybate (indicated in narcolepsy type 1, nt1) has not been tested in ih patients. |
2016-12-13 |
2023-08-13 |
Not clear |
| Monica Moresco, Laura Natalia Riccardi, Fabio Pizza, Corrado Zenesini, Leonardo Caporali, Giuseppe Plazzi, Susi Pelott. Pharmacogenetics and Treatment Response in Narcolepsy Type 1: Relevance of the Polymorphisms of the Drug Transporter Gene ABCB1. Clinical neuropharmacology. vol 39. issue 1. 2016-10-11. PMID:26757307. |
narcolepsy type 1 (nt1) is a chronic hypersomnia clinically characterized by daytime sleepiness and cataplexy. |
2016-10-11 |
2023-08-13 |
Not clear |
| Monica Moresco, Laura Natalia Riccardi, Fabio Pizza, Corrado Zenesini, Leonardo Caporali, Giuseppe Plazzi, Susi Pelott. Pharmacogenetics and Treatment Response in Narcolepsy Type 1: Relevance of the Polymorphisms of the Drug Transporter Gene ABCB1. Clinical neuropharmacology. vol 39. issue 1. 2016-10-11. PMID:26757307. |
narcolepsy type 1 patients variably respond to modafinil and venlafaxine independently of individual clinical features.given the potential influence of drug transmembrane transport (glycoprotein-p) on drug response, we explored the relation between genetic polymorphisms in the abcb1 gene and clinical response to modafinil/venlafaxine in nt1. |
2016-10-11 |
2023-08-13 |
Not clear |
| Lucie Barateau, Régis Lopez, Yves Dauvillier. Management of Narcolepsy. Current treatment options in neurology. vol 18. issue 10. 2016-08-23. PMID:27549768. |
narcolepsy type 1 (nt1) and type 2 (nt2) are two rare neurological diseases, classified as central disorders of hypersomnolence. |
2016-08-23 |
2023-08-13 |
Not clear |
| Francisco Javier Martinez-Orozco, Jose Luis Vicario, Clara De Andres, Miguel Fernandez-Arquero, Rosa Peraita-Adrado. Comorbidity of Narcolepsy Type 1 With Autoimmune Diseases and Other Immunopathological Disorders: A Case-Control Study. Journal of clinical medicine research. vol 8. issue 7. 2016-06-14. PMID:27298657. |
narcolepsy type 1 (nt1) is a chronic sleep disorder caused by a selective loss of hypocretin-producing neurons due to a mechanism of neural destruction that indicates an autoimmune pathogenesis, although no evidence is available. |
2016-06-14 |
2023-08-13 |
Not clear |
| Giuseppe Plazzi, Chiara Fabbri, Fabio Pizza, Alessandro Serrett. Schizophrenia-like symptoms in narcolepsy type 1: shared and distinctive clinical characteristics. Neuropsychobiology. vol 71. issue 4. 2016-05-27. PMID:26279454. |
the occurrence of psychotic symptoms in narcolepsy type 1 (nt1) has been reported as responsible for delayed diagnosis due to the misdiagnosis of schizophrenia. |
2016-05-27 |
2023-08-13 |
Not clear |
| Fabio Pizza, Isabelle Jaussent, Regis Lopez, Carole Pesenti, Giuseppe Plazzi, Xavier Drouot, Smaranda Leu-Semenescu, Severine Beziat, Isabelle Arnulf, Yves Dauvillier. Car Crashes and Central Disorders of Hypersomnolence: A French Study. PloS one. vol 10. issue 6. 2016-02-29. PMID:26052938. |
narcolepsy type 1 (nt1), narcolepsy type 2 (nt2) and idiopathic hypersomnia (ih) are rare central disorders of hypersomnolence, the most severe causes of sleepiness thus being potential dangerous conditions for both personal and public safety with increasing scientific, social, and political attention. |
2016-02-29 |
2023-08-13 |
human |